Back to Trades
Total Value
$NaN
Filing Date
Jul 17, 2026
1 transactions
Trade Summary
On Jul 9, 2026, Volles Warren Karl, Chief Legal Officer, reported $NaN of Biohaven Ltd. (BHVN) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Biohaven Ltd.
- Ticker Symbol
- BHVN
- CIK
- 0001935979
Insider Information
- Role
- Chief Legal Officer
- Location
- NEW HAVEN, CT
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 9, 2026
- Accession Number
- 0002146037-26-000003
- Form Type
- 3
Want live alerts when Volles Warren Karl trades again?
Download Insider Trades to track BHVN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This balance includes 742 shares, 1,086 shares, 2 shares, and 2,500 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2024, May 31, 2025, November 30, 2025, and May 31, 2026, respectively.
- (F2)The shares underlying this option became exercisable on and prior to October 3, 2025.
- (F3)The shares underlying this option became exercisable as to 59,063 of these shares on and prior to November 2, 2025, with the remainder vesting on November 2, 2026, subject to the Reporting Person's continued service with the Issuer at the vesting date.
- (F4)The shares underlying this option became exercisable as to 72,188 of these shares on and prior to January 2, 2026, with the remainder vesting on January 2, 2027, subject to the Reporting Person's continued service with the Issuer at the vesting date.
- (F5)The shares underlying this option became exercisable as to 41,500 of these shares on and prior to January 5, 2026, with the remainder vesting in two equal installments on January 5, 2027, and 2028, subject to the Reporting Person's continued service with the Issuer at each vesting date.
- (F6)The shares underlying this option became exercisable as to 43,750 of these shares on February 27, 2026, with the remainder vesting in three equal installments on February 27, 2027, 2028, and 2029, subject to the Reporting Person's continued service with the Issuer at each vesting date.
- (F7)The reporting person was granted 14,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027, and 2028, subject to the Reporting Person's continued service with the Issuer at each vesting date.
- (F8)Not applicable.
- (F9)Each restricted share unit represents the contingent right to receive one common share of the Issuer.